Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
The Dilemma of Renal Involvement in COVID-19: A Systematic Review
Hamza Bajwa1, Yumna Riaz1, Muhammad Ammar2
1Internal Medicine, King Edward Medical University, Mayo Hospital, Lahore, PAK.
Insights
COVID-19 patients with acute kidney insufficiency face severe illness and high mortality rates. This highlights the critical need for monitoring kidney health in these patients, especially those with pre-existing kidney conditions.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a global health challenge.
- Older adults and those with comorbidities experience more severe COVID-19 outcomes.
- Understanding acute kidney injury (AKI) in COVID-19 is vital for explaining severe patient prognoses.
Purpose of the Study:
- To review the prevalence and mortality rates of acute kidney insufficiency in COVID-19 patients.
- To analyze the clinical course and outcomes of COVID-19 patients who develop AKI.
- To emphasize the risks for patients with pre-existing kidney disease.
Main Methods:
- Literature review including studies on COVID-19 patient prevalence and mortality with AKI.
- Analysis of data from 1098 COVID-19 positive patients.
- Focus on identifying specific mortality rates and disease severity in patients with AKI.
Main Results:
- 66 out of 1098 (6%) COVID-19 patients developed acute kidney insufficiency.
- A high mortality rate of 94% (62 deaths) was observed in COVID-19 patients with AKI.
- Patients with AKI experienced more severe disease courses and higher ICU admission rates.
Conclusions:
- Acute kidney insufficiency is a significant complication of COVID-19, associated with severe outcomes and high mortality.
- COVID-19 patients with pre-existing kidney disease, including chronic kidney disease and transplant recipients on immunosuppression, require heightened vigilance.
- Further research into the pathogenesis of AKI in COVID-19 is warranted to improve patient management and outcomes.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), now known as coronavirus disease 2019 (COVID-19), has posed a serious threat to global health since December 2019. It has spread worldwide and is consuming healthcare resources rapidly. Published literature suggests that people with advanced age and comorbidities are affected more severely. It is crucial to uncover the underlying pathogenesis of acute kidney insufficiency in COVID-19 patients to understand better the reasoning behind the grave outcomes in these patients. In this review, we have included articles stating the prevalence and specific mortality rates of COVID-19 patients with acute kidney insufficiency. Our study included 1098 COVID-19 positive patients, of whom 66 (6%) developed acute kidney insufficiency and 62 patients died, showing a mortality rate of 94%. Patients with acute kidney insufficiency showed a more severe disease course, and these patients ended up more in intensive care units. Particular attention should be paid to those with already established kidney disease, such as chronic kidney disease, or renal transplant recipients, as these patients are already on immunosuppressive therapy. Our review focuses on the prevalence of acute kidney insufficiency in COVID-19 patients and mortality rates in this subset of patients.
Related Concept Videos
Pneumonia III: Complications and Assessment
Acute Kidney Injury III: Clinical Manifestations
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Kidney Injury II: Pathophysiology

